{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:36:18Z","timestamp":1775018178768,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1208\/s12249-018-1242-6","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T10:54:42Z","timestamp":1546426482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["5\u03b2-Cholanic Acid\/Glycol Chitosan Self-Assembled Nanoparticles (5\u03b2-CHA\/GC-NPs) for Enhancing the Absorption of FDs and Insulin by Rat Intestinal Membranes"],"prefix":"10.1208","volume":"20","author":[{"given":"Chengyun","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuguang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,2]]},"reference":[{"issue":"PtB","key":"1242_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","volume":"106","author":"Z Niu","year":"2016","unstructured":"Niu Z, Conejos-S\u00e1nchez I, Griffin BT, O\u2019Driscoll CM, Alonso MJ. Lipid-based nanocarriers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106(PtB):337\u201354.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1242_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijpharm.2017.11.034","volume":"536","author":"T Yin","year":"2017","unstructured":"Yin T, Zhang Y, Liu Y, Chen Q, Fu Y, Liang J, et al. The efficiency and mechanism of N-octyl-O, N-carboxymethyl chitosan-based micelles to enhance the oral absorption of silybin. Int J Pharm. 2017;536(1):231\u201340.","journal-title":"Int J Pharm"},{"key":"1242_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.18433\/J3CK88","volume":"20","author":"M Arafat","year":"2017","unstructured":"Arafat M, Kirchhoefer C, Mikov M, Sarfraz M, L\u00f6benberg R. Nanosized liposomes containing bile salt: a vesicular nanocarrier for enhancing oral bioavailability of BCS class III drug. J Pharm Pharm Sci. 2017;20:305\u201318.","journal-title":"J Pharm Pharm Sci"},{"issue":"11","key":"1242_CR4","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1021\/acs.molpharmaceut.6b00691","volume":"13","author":"D Pooja","year":"2016","unstructured":"Pooja D, Kulhari H, Kuncha M, Rachamalla SS, Adams DJ, Bansal V, et al. Improving efficacy, oral bioavailability, and delivery of paclitaxel using protein-grafted solid lipid nanoparticles. Mol Pharm. 2016;13(11):3903\u201312.","journal-title":"Mol Pharm"},{"issue":"6","key":"1242_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3109\/10837450.2014.915570","volume":"20","author":"A Mooranian","year":"2015","unstructured":"Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, et al. An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharm Dev Technol. 2015;20(6):702\u20139.","journal-title":"Pharm Dev Technol"},{"key":"1242_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0169-409X(00)00123-X","volume":"47","author":"KA Janes","year":"2001","unstructured":"Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 2001;47:83\u201397.","journal-title":"Adv Drug Deliv Rev"},{"key":"1242_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0378-5173(92)90353-4","volume":"78","author":"CM Lehr","year":"1992","unstructured":"Lehr CM, Bouwstra JA, Schacht E, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm. 1992;78:43\u20138.","journal-title":"Int J Pharm"},{"key":"1242_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1021\/js960182o","volume":"86","author":"TJ Aspden","year":"1997","unstructured":"Aspden TJ, Mason JD, Jones NS. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci. 1997;86:509\u201313.","journal-title":"J Pharm Sci"},{"key":"1242_CR9","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.2147\/IJN.S116063","volume":"12","author":"GR Barbari","year":"2017","unstructured":"Barbari GR, Dorkoosh FA, Amini M, Sharifzadeh M, Atyabi F, Balalaie S, et al. A novel nanoemulsion-based method to produce ultrasmall, water-dispersible nanoparticles from chitosan, surface modified with cell-penetrating peptide for oral delivery of proteins and peptides. Int J Nanomedicine. 2017;12:3471\u201383.","journal-title":"Int J Nanomedicine"},{"issue":"12","key":"1242_CR10","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3109\/03639045.2015.1044904","volume":"41","author":"J Hecq","year":"2015","unstructured":"Hecq J, Siepmann F, Siepmann J, Amighi K, Goole J. Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration. Drug Dev Ind Pharm. 2015;41(12):2037\u201344.","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"1242_CR11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1021\/mp200572t","volume":"9","author":"K Sonaje","year":"2012","unstructured":"Sonaje K, Chuang EY, Lin KJ, Yen TC, Su FY, Tseng MT, et al. Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. Mol Pharm. 2012;9(5):1271\u20139.","journal-title":"Mol Pharm"},{"key":"1242_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0168-3659(00)00361-8","volume":"70","author":"HQ Mao","year":"2001","unstructured":"Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. 2001;70:399\u2013421.","journal-title":"J Control Release"},{"key":"1242_CR13","first-page":"295","volume":"12","author":"P Yinbo","year":"2017","unstructured":"Yinbo P, Chenlu S, Chuanfeng Y, Qige G, Min Y. Low molecular weight chitosan-coated silver nanoparticles are effective for the treatmentof MRSA-infected wounds. Int J Nanomedicine. 2017;12:295\u2013304.","journal-title":"Int J Nanomedicine"},{"key":"1242_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.carbpol.2007.06.016","volume":"71","author":"L Zeng","year":"2008","unstructured":"Zeng L, Qin C, Wang W, Chi W, Li W. Absorption and distribution of chitosan in mice after oral administration. Carbohydr Polym. 2008;71:435\u201340.","journal-title":"Carbohydr Polym"},{"issue":"3","key":"1242_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jconrel.2005.12.015","volume":"111","author":"C Prego","year":"2006","unstructured":"Prego C, Torres D, Fernandez-Megia E, Novoa-Carballal R, Qui\u00f1o\u00e1 E, Alonso MJ. Chitosan\u2013PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. J Control Release. 2006;111(3):299\u2013308.","journal-title":"J Control Release"},{"key":"1242_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jconrel.2014.05.009","volume":"193","author":"JY Yhee","year":"2014","unstructured":"Yhee JY, Son S, Kim SH, Park K, Choi K, Kwon IC. Self-assembled glycol chitosan nanoparticles for disease-specific theranostics. J Control Release. 2014;193:202\u201313.","journal-title":"J Control Release"},{"key":"1242_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2011.03.027","volume":"152","author":"SJ Lee","year":"2011","unstructured":"Lee SJ, Koo H, Jeong H, Huh MS, Choi Y, Jeong SY, et al. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. J Control Release. 2011;152:21\u20139.","journal-title":"J Control Release"},{"issue":"1","key":"1242_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jconrel.2010.01.021","volume":"144","author":"L Tieshi","year":"2010","unstructured":"Tieshi L, Lara L, Froilan GM, Timothy JM, Yun Y, Anna S. Use of glycol chitosan modified by 5\u03b2-cholanic acid nanoparticles for the sustained release of proteins during murine embryonic limb skeletogenesis. J Control Release. 2010;144(1):101\u20138.","journal-title":"J Control Release"},{"issue":"7","key":"1242_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s12272-001-1247-9","volume":"31","author":"GJ Hyung","year":"2008","unstructured":"Hyung GJ, Kyung HM, Tae HN, Seong JN, Jae HP, Seo YJ. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats. Arch Pharm Res. 2008;31(7):918\u201323.","journal-title":"Arch Pharm Res"},{"issue":"4","key":"1242_CR20","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1021\/bm034094r","volume":"4","author":"JH Park","year":"2003","unstructured":"Park JH, Cho YW, Chung H, Kwon IC, Jeong SY. Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability. Biomacromolecules. 2003;4(4):1087\u201391.","journal-title":"Biomacromolecules"},{"issue":"1","key":"1242_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jps.20399","volume":"95","author":"Y Zheng","year":"2005","unstructured":"Zheng Y, Wu Y, Yang W, Wang C, Fu S, Shen X. Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles. J Pharm Sci. 2005;95(1):181\u201391.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1242_CR22","first-page":"249","volume":"349","author":"E Farnaz","year":"2008","unstructured":"Farnaz E, Mohammad HG, Behnaz E, Mohammad RK, Fatemeh A, Rassoul D. PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int J Pharmaceut. 2008;349(1):249\u201355.","journal-title":"Int J Pharmaceut"},{"key":"1242_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jconrel.2005.05.017","volume":"106","author":"G Fetih","year":"2005","unstructured":"Fetih G, Habib F, Okada N, Fujita T, Attia M, Yamamoto A. Nitricoxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. J Control Release. 2005;106:287\u201397.","journal-title":"J Control Release"},{"key":"1242_CR24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s13346-017-0373-8","volume":"7","author":"Y Chengyun","year":"2017","unstructured":"Chengyun Y, Jiwei G, Yuguang L, Weiguo S, Hongying J. Improved intestinal absorption of water-soluble drugs by acetylation of G2 PAMAM dendrimer nanocomplexes in rat. Drug Deliv Transl Res. 2017;7:408\u201315.","journal-title":"Drug Deliv Transl Res"},{"key":"1242_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jconrel.2013.08.297","volume":"172","author":"H Koo","year":"2013","unstructured":"Koo H, Min KH, Lee SC, Park JH, Park K, Jeong SY, et al. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery. J Control Release. 2013;172:823\u201331.","journal-title":"J Control Release"},{"key":"1242_CR26","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1023\/A:1011032328064","volume":"18","author":"A Lamprecht","year":"2001","unstructured":"Lamprecht A, Schafer U, Lehr CM. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res. 2001;18:788\u201393.","journal-title":"Pharm Res"},{"key":"1242_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jconrel.2005.12.013","volume":"111","author":"JH Kim","year":"2006","unstructured":"Kim JH, Kim YS, Kim S, Park JH, Kim K, Choi K, et al. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release. 2006;111:228\u201334.","journal-title":"J Control Release"},{"issue":"24","key":"1242_CR28","doi-asserted-by":"publisher","first-page":"10188","DOI":"10.1021\/la0350608","volume":"19","author":"S Kwon","year":"2003","unstructured":"Kwon S, Park JH, Chung H, Kwon IC, Jeong SY. Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5-cholanic acid. Langmuir. 2003;19(24):10188\u201393.","journal-title":"Langmuir"},{"key":"1242_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0169-409X(00)00120-4","volume":"47","author":"H Takeuchi","year":"2001","unstructured":"Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev. 2001;47:39\u201355.","journal-title":"Adv Drug Deliv Rev"},{"key":"1242_CR30","first-page":"988","volume-title":"Proceedings of 26th international symposiumon controlled release of bioactive materials","author":"H Takeuchi","year":"1999","unstructured":"Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. Mucoadhesive liposomes coated with chitosan or carbopol for oral administration of peptide drugs. In: Proceedings of 26th international symposiumon controlled release of bioactive materials; 1999. p. 988\u20139."},{"key":"1242_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jconrel.2003.12.020","volume":"95","author":"JH Park","year":"2004","unstructured":"Park JH, Kwon S, Nam JO, Park RW, Chung H, Seo SB, et al. Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery. J Control Release. 2004;95:579\u201388.","journal-title":"J Control Release"},{"key":"1242_CR32","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.biomaterials.2007.12.038","volume":"29","author":"JH Kim","year":"2008","unstructured":"Kim JH, Kim YS, Park K, Kang E, Lee S, Nam HY, et al. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials. 2008;29:1920\u201330.","journal-title":"Biomaterials"},{"key":"1242_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijpharm.2013.02.024","volume":"446","author":"Z Yuan","year":"2013","unstructured":"Yuan Z, Ye Y, Gao F, Yuan H, Lan M, Lou K, et al. Chitosan-graft-\u03b2-cyclodextrin nanoparticles as a carrier for controlled drug release. Int J Pharm. 2013;446:191\u20138.","journal-title":"Int J Pharm"},{"issue":"3","key":"1242_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2008.03.019","volume":"128","author":"K Park","year":"2008","unstructured":"Park K, Hong HY, Moon HJ, Lee BH, Kim IS, Kwon IC, et al. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides. J Control Release. 2008;128(3):217\u201323.","journal-title":"J Control Release"},{"key":"1242_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0168-3659(03)00160-3","volume":"20","author":"K Yamabe","year":"2003","unstructured":"Yamabe K, Kato Y, Onishi H, Machida Y. Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. J Control Release. 2003;20:429\u201336.","journal-title":"J Control Release"},{"key":"1242_CR36","first-page":"91","volume":"8","author":"VHL Lee","year":"1991","unstructured":"Lee VHL, Yamamoto A, Kompella UB. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit Rev Ther Drug Carrier Syst. 1991;8:91\u20132.","journal-title":"Crit Rev Ther Drug Carrier Syst"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-1242-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1242-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1242-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T19:06:44Z","timestamp":1577905604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-1242-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1242-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"11 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"30"}}